Deepinder Goyal, co-founder of Zomato and founder of Eternal, is currently drawing significant attention online due to his use of a new health wearable device positioned near his temple. A fellow founder on LinkedIn speculated that this device represents a breakthrough in health wearables by continuously monitoring brain blood flow, a critical biomarker potentially linked to aging and cognition. The device is nicknamed TEMPLE, highlighting its placement near the temple region of the head.
Deepinder Goyal’s Response
In response, Goyal explained that the need to study brain blood flow accuraely and continuously arose during his work on the Gravity Aging Hypothesis. The device was built experimentally for that purpose and he has personally been using it for about a year. While still early, Goyal believes that whether or not the hypothesis is validated, the device is useful and relevant as brain blood flow is already an accepted biomarker for aging and cognition.
Goyal emphasized that Temple will likely remain a small, specialized company distinct from Eternal, his larger venture. Importantly, Goyal clarified that the Gravity Aging Hypothesis was not created as a marketing gimmick to sell the device, underscoring his commitment to maintaining the trust of his customers and community.
This conversation highlights the intersection of longevity research, neuroscience, and wearable technology, with TEMPLE representing a novel tool for real-time brain health monitoring. If successful, it could enable personalized health insights and interventions that contribute to longer, healthier lives.
The speculation and Goyal’s candid reply together suggest that the wearable may pioneer a new product category focused on brain flow as a core physiological metric, with global implications for anti-aging and cognitive health.
Images shared online show the device is compact, designed for comfort and continuous wear, reinforcing its potential role in the future of health tech innovation.
